Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The webpage has updated its results reporting dates, with new dates for submissions and postings, and has added specific study documents from Memorial Sloan Kettering Cancer Center.
    Difference
    3%
    Check dated 2025-05-08T04:59:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T00:58:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II study evaluating the efficacy of the IDO1 inhibitor, epacadostat, in combination with pembrolizumab for patients with metastatic and/or locally advanced grade sarcomas. Key collaborators have been listed, and the revision number has been updated.
    Difference
    54%
    Check dated 2025-04-16T14:10:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 5, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T08:41:51.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:25:33.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The webpage has updated its service availability information, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several dates have been updated, reflecting changes in the timeline for future events.
    Difference
    2%
    Check dated 2025-02-10T09:39:42.000Z thumbnail image

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.